0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Paratek Pharmaceuticals - logo

Paratek Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of therapeutics based upon tetracycline chemistry. Its lead product candidates include Omadacycline and Sarecycline, both of which are undergoing clinical trials. It has collaborative research and license agreement with Allergan plc to research and develop tetracycline products. Paratek was incorporated in 2001 and is based in Boston, Massachusetts.

From
EUR$4,750USDGBP
MTOR Inhibitors Market Report 2025 - Product Thumbnail Image

MTOR Inhibitors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Anthrax - Pipeline Insight, 2025 - Product Thumbnail Image

Anthrax - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
EUR$1,500USDGBP
From
EUR$4,750USDGBP
From
EUR$7,500USDGBP
From
EUR$4,750USDGBP
From
EUR$495USDGBP
From
EUR$595USDGBP
Paratek Pharmaceuticals Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

Paratek Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • September 2024
  • 33 Pages
From
EUR$125USDGBP
Loading Indicator
This website uses cookies to ensure you get the best experience. Learn more